{
    "title": "Somatids, The Somatoscope, & 714X",
    "inventor_name": "Gaston Naessens",
    "publication_year": null,
    "device_name": "714X",
    "goal": "Alternative treatment of cancer by normalising somatids and restoring immune function.",
    "problem_addressed": "Cancer (tumour development and progression).",
    "concept_summary": "714X is an injectable (and nebulisable) mixture containing camphor, ammonium salts, nitrates, sodium chloride, ethanol, water and nitrogen. It is claimed to fluidify lymph, deliver nitrogen to cancer cells, neutralise a purported tumour-derived factor (CKF) and unblock the immune system, thereby restoring normal somatid cycles and inhibiting cancer growth.",
    "detailed_description": "The product is administered daily by intralymphatic injection into a groin lymph node for 21 days per cycle (typically three cycles). A secondary nasal administration using a nebuliser is optional for lung/oral cancers. The formulation lists camphor as the vehicle, ammonium salts to improve lymph circulation, and nitrogen as the active ingredient. The inventor also developed a \"somatoscope\" microscope to observe microscopic particles (somatids) in blood, which he claimed are involved in disease. No peer-reviewed clinical data support the efficacy; regulatory bodies have investigated the product.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Nitrogen delivery to lymphatic system",
        "Camphor affinity for cancer cells",
        "Ammonium salts enhance lymph circulation",
        "Neutralisation of tumour-derived CKF factor",
        "Fluidification of lymph to unblock immune response"
    ],
    "scientific_domains": [
        "Oncology",
        "Immunology",
        "Pharmacology",
        "Alternative Medicine",
        "Medical Physics"
    ],
    "mechanisms_of_action": [
        "Fluidify lymphatic fluid",
        "Transport nitrogen to cancerous cells",
        "Neutralise CKF (cocancerogenic K factor)",
        "Unblock dysfunctional immune system",
        "Restore normal somatid life-cycle"
    ],
    "materials": [
        "Camphor",
        "Ammonium chloride",
        "Nitrate",
        "Sodium chloride",
        "Ethanol",
        "Water",
        "Nitrogen",
        "Aluminum (trace)",
        "Antimony (trace)",
        "Arsenic (trace)",
        "Barium (trace)",
        "Bore (trace)",
        "Cadmium (trace)",
        "Calcium (trace)",
        "Chromium (trace)",
        "Cobalt (trace)",
        "Copper (trace)",
        "Iron (trace)",
        "Lead (trace)",
        "Magnesium (trace)"
    ],
    "energy_sources": [],
    "inputs": [
        "Daily intralymphatic injection (21 days per cycle)",
        "Optional nebuliser inhalation (0.6 mL in 1.9 mL saline)"
    ],
    "outputs": [
        "Claimed reduction of cancerous cells",
        "Restoration of normal somatid cycles",
        "Strengthened immune response",
        "Minimal side effects (burning sensation at injection site)"
    ],
    "claimed_performance": "Reported to fluidify lymph, deliver nitrogen to cancer cells, neutralise CKF, unblock immune system and halt toxic secretions; side effects described as minimal, primarily burning sensation at injection site.",
    "experimental_evidence": "\"There have been few published animal studies of the safety and effectiveness of 714-X, and those that have been conducted have shown no beneficial effect.\" (Kaegi)",
    "replication_status": null,
    "keywords": [
        "cancer",
        "somatids",
        "lymphatic injection",
        "camphor",
        "nitrogen therapy",
        "immune modulation",
        "alternative medicine"
    ],
    "related_technologies": [
        "Somatoscope",
        "Ultramicroscope",
        "Nebuliser"
    ],
    "controversy_level": "high",
    "confidence_score": 0.78,
    "practicability_score": 0.45,
    "fringe_score": 0.85,
    "evidence_strength": 0.2,
    "risk_score": 0.55,
    "trl_estimate": 3,
    "source_urls": [
        "http://www.bccancer.bc.ca/PPI/UnconventionalTherapies/GastonNaessens714X.htm",
        "http://www.cerbe.com/en/techdata.html"
    ],
    "organizations": [
        "Centre d'Orthobiologie Somatidienne de l'Estrie (C.O.S.E.)",
        "C.E.R.B.E. inc. (Centre experimental de recherches biologiques de l'Estrie Inc.)",
        "CERBE Distribution Inc."
    ],
    "applications": [
        "Alternative cancer therapy",
        "Immune system support"
    ],
    "limitations": [
        "No peer-reviewed clinical data supporting efficacy",
        "Regulatory investigation by Health Canada and FDA",
        "Complex daily intralymphatic administration",
        "Potential camphor toxicity when taken internally"
    ],
    "open_questions": [
        "What is the true biological nature of \"somatids\"?",
        "Does nitrogen delivered via lymphatic injection affect cancer cells?",
        "Can the claimed CKF neutralisation be demonstrated experimentally?",
        "What are the long-term safety effects of repeated camphor exposure?",
        "Can the treatment be scaled and standardized?"
    ],
    "red_flags": [
        "Unproven efficacy and lack of reproducible data",
        "Regulatory scrutiny and investigation",
        "Claims contradict mainstream cancer biology",
        "Potential toxicity of camphor and trace metals"
    ],
    "evidence_quotes": [
        "\"There have been few published animal studies of the safety and effectiveness of 714-X, and those that have been conducted have shown no beneficial effect.\" (Kaegi)",
        "\"714X contains a mixture of camphor, ammonium chloride and nitrate, sodium chloride, ethanol, and water.\" (Health)",
        "\"The goal is to fluidify the lymph, and to direct nitrogen to the cancerous cells in order to stop their toxic secretions, which block the organism's defense mechanism.\" (Fink 1997)",
        "\"714X has no (reported) side effects but should be used only with the supervision of a physician.\" (Fink 1988)",
        "\"The product is administered daily by intralymphatic injection into a groin lymph node for 21 days per cycle.\" (Fink 1997)"
    ]
}